Literature DB >> 7744895

The severely unstable hip in cerebral palsy. Treatment with open reduction, pelvic osteotomy, and femoral osteotomy with shortening.

L Root1, F J Laplaza, S N Brourman, D H Angel.   

Abstract

The results in thirty-one patients with cerebral palsy who had a total of thirty-five severely subluxated or dislocated hips were analyzed retrospectively a mean of seven years after open reduction, pelvic osteotomy, varus rotational osteotomy, and femoral shortening. Preoperatively, twenty-two patients had been unable to stand and thirteen had had pain; the mean acetabular index was 50 degrees, the mean center-edge angle was -19 degrees, and the mean migration index was 74 percent. At the latest follow-up examination, none of the hips were painful. Seven patients had an improvement of one level in their walking ability. All of the patients who were confined to a wheelchair had better sitting balance. The mean acetabular index was 40 degrees, the mean center-edge angle was 18 degrees, and the mean migration index was 25 percent. Four hips were subluxated (two of them posteriorly). One hip was treated with a repeat varus rotational osteotomy. Another hip, which was not dislocated, had a rotational osteotomy for excessive femoral anteversion. Eight femoral heads displayed signs of avascular necrosis. One tibial and two femoral fractures occurred after the cast was removed. Three of the four patients who had a subluxated hip had scoliosis. The combined approach improved coverage of the femoral head and decreased pain in the hip. Even though this procedure can be accompanied by serious complications, we believe that the results justify this extensive approach in these patients.

Entities:  

Mesh:

Year:  1995        PMID: 7744895     DOI: 10.2106/00004623-199505000-00006

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  20 in total

1.  Reconstruction of dislocated hips in children with cerebral palsy.

Authors:  J D Spencer
Journal:  BMJ       Date:  1999-04-17

2.  Early results of one-stage correction for hip instability in cerebral palsy.

Authors:  Hui Taek Kim; Jae Hoon Jang; Jae Min Ahn; Jong Seo Lee; Dong Joon Kang
Journal:  Clin Orthop Surg       Date:  2012-05-17

3.  Risk factors and complications in hip reconstruction for nonambulatory patients with cerebral palsy.

Authors:  Joseph J Ruzbarsky; Nicholas A Beck; Keith D Baldwin; Wudbhav N Sankar; John M Flynn; David A Spiegel
Journal:  J Child Orthop       Date:  2013-10-15       Impact factor: 1.548

4.  Long-term followup of total hip arthroplasty in patients with cerebral palsy.

Authors:  Bradley S Raphael; Joshua S Dines; Meredith Akerman; Leon Root
Journal:  Clin Orthop Relat Res       Date:  2009-11-19       Impact factor: 4.176

5.  Observations on the development of the acetabulum following Chiari osteotomy.

Authors:  W R Osebold; E L Lester; Patrice Watson
Journal:  Iowa Orthop J       Date:  2002

6.  Painful spastic hip dislocation: proximal femoral resection.

Authors:  Javier Albiñana; Gaspar Gonzalez-Moran
Journal:  Iowa Orthop J       Date:  2002

Review 7.  [The hip joint in neuromuscular disorders].

Authors:  W M Strobl
Journal:  Orthopade       Date:  2009-07       Impact factor: 1.087

8.  Neurogenic hip dislocation in cerebral palsy: quality of life and results after hip reconstruction.

Authors:  Alexander Krebs; Walter M Strobl; Franz Grill
Journal:  J Child Orthop       Date:  2008-02-13       Impact factor: 1.548

9.  Abduction pillow immobilization following hip surgery: a welcome alternative for selected patients.

Authors:  Josh Albrektson; Robert M Kay; Vernon T Tolo; David L Skaggs
Journal:  J Child Orthop       Date:  2007-10-13       Impact factor: 1.548

10.  Proximal femoral excision with interposition myoplasty for cerebral palsy patients with painful chronic hip dislocation.

Authors:  Nirav K Patel; Sanjeeve Sabharwal; Christopher R Gooding; Aresh Hashemi-Nejad; Deborah M Eastwood
Journal:  J Child Orthop       Date:  2015-06-28       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.